Alain Baron

16.9k total citations · 4 hit papers
70 papers, 13.7k citations indexed

About

Alain Baron is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Alain Baron has authored 70 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 23 papers in Cardiology and Cardiovascular Medicine and 19 papers in Molecular Biology. Recurrent topics in Alain Baron's work include Diabetes Treatment and Management (24 papers), Diabetes Management and Research (18 papers) and Metabolism, Diabetes, and Cancer (17 papers). Alain Baron is often cited by papers focused on Diabetes Treatment and Management (24 papers), Diabetes Management and Research (18 papers) and Metabolism, Diabetes, and Cancer (17 papers). Alain Baron collaborates with scholars based in United States, Australia and China. Alain Baron's co-authors include Mark Fineman, Dennis Dong Hwan Kim, Kieren J. Mather, Michael J. Quon, Arie Katz, Gail W. Sullivan, Dean Follmann, Sridhar Nambi, Jenny Han and John B. Buse and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and PLoS ONE.

In The Last Decade

Alain Baron

68 papers receiving 13.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans

2000 3.2k citations Kieren J. Mather, Alain Baron et al. The Journal of Clinical Endocrinology & Metabolism profile →
Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

2005 1.2k citations Dennis Dong Hwan Kim, Mark Fineman et al. profile →
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

2004 1.1k citations Robert R. Henry, Dennis Dong Hwan Kim et al. profile →
Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

2005 959 citations Dennis Dong Hwan Kim, Mark Fineman et al. profile →

Peers

Countries citing papers authored by Alain Baron

Since Specialization

Citations

This map shows the geographic impact of Alain Baron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Baron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Baron more than expected).

Fields of papers citing papers by Alain Baron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Baron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Baron. The network helps show where Alain Baron may publish in the future.

Co-authorship network of co-authors of Alain Baron

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Baron. A scholar is included among the top collaborators of Alain Baron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Baron. Alain Baron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-affinity agonists reveal recognition motifs for the MRGPRD GPCR 2024 ·Cell Reports ·Chunyu Wang, Yongfeng Liu, Marion Lanier, (unknown), Isha Singh, Ryan H. Gumpper, B. Krumm, (unknown), Shicheng Zhang, Marcus F. Boehm, Richard Pittner, Alain Baron, Lisa Dvorak, (unknown), Brian K. Shoichet, Esther Martinborough, Jonathan F. Fay, Can Cao, Bryan L. Roth	1
2	Improved glycemic control with minimal systemic metformin exposure: Effects of Metformin Delayed-Release (Metformin DR) targeting the lower bowel over 16 weeks in a randomized trial in subjects with type 2 diabetes 2018 ·PLoS ONE ·Robert R. Henry, Juan P. Frías, Brandon Walsh, (unknown), John Hemming, Colleen Burns, Thomas A. Bicsak, Alain Baron, Mark Fineman	21
3	The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats 2010 ·Cardiovascular Diabetology ·Que Liu, (unknown), (unknown), (unknown), Alain Baron, David G. Parkes	54
4	Amylin-Mediated Restoration of Leptin Responsiveness in Diet-Induced Obesity: Magnitude and Mechanisms 2008 ·Endocrinology ·James L. Trevaskis, Todd Coffey, Rebecca L. Cole, Chunli Lei, Carrie Wittmer, Brandon Walsh, Christian Weyer, Joy E. Koda, Alain Baron, David G. Parkes, Jonathan D. Roth	125
5	Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies 2008 ·Proceedings of the National Academy of Sciences ·Jonathan D. Roth, Barbara Roland, Rebecca L. Cole, James L. Trevaskis, Christian Weyer, Joy E. Koda, Christen M. Anderson, David G. Parkes, Alain Baron	348
6	Hyperinsulinemia fails to augment ET-1 action in the skeletal muscle vascular bed in vivo in humans 2008 ·American Journal of Physiology-Endocrinology and Metabolism ·Amale Lteif, Angie D. Fulford, Robert V. Considine, (unknown), Alain Baron, Kieren J. Mather	12
7	Antiobesity Effects of the β-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression 2006 ·Endocrinology ·Jonathan D. Roth, Heather Hughes, (unknown), Alain Baron, Christen M. Anderson	140
8	Emerging therapies: controlling glucose homeostasis, immunotherapy, islet transplantation, gene therapy, and islet cell neogenesis and regeneration 2004 ·Endocrinology and Metabolism Clinics of North America ·James A. Ruggles, (unknown), Alain Baron	10
9	Effectiveness of progressive dose‐escalation of exenatide (exendin‐4) in reducing dose‐limiting side effects in subjects with type 2 diabetes 2004 ·Diabetes/Metabolism Research and Reviews ·Mark Fineman, Larry Z. Shen, Kristin Taylor, Dennis Dong Hwan Kim, Alain Baron	193
10	Exenatide (Exendin-4) Improves Insulin Sensitivity and β-Cell Mass in Insulin-Resistant Obesefa/faZucker Rats Independent of Glycemia and Body Weight 2004 ·Endocrinology ·Bronislava Gedulin, Svetlana E. Nikoulina, Pam Smith, (unknown), Loretta L. Nielsen, Alain Baron, David G. Parkes, Andrew A. Young	202
11	Insulin resistance and vascular function 2002 ·Journal of Diabetes and its Complications ·Alain Baron	116
12	Impaired glucose tolerance as a disease 2001 ·The American Journal of Cardiology ·Alain Baron	43
13	Dose-response relationship of insulin to glucose fluxes in the awake and unrestrained mouse 1999 ·Metabolism ·(unknown), J S Zhu, Alain Baron	14
14	Vascular reactivity 1999 ·The American Journal of Cardiology ·Alain Baron	76
15	Postprandial hyperglycaemia and α-glucosidase inhibitors 1998 ·Diabetes Research and Clinical Practice ·Alain Baron	272
16	PROTECT interim results: a large multicenter study of patients with type II diabetes 1997 ·Clinical Therapeutics ·Alain Baron, Christopher Neumann	19
17	Pathogenesis and measurement of insulin resistance in hypertension 1994 ·Current Opinion in Nephrology & Hypertension ·Alain Baron	14
18	Mechanism of Insulin Resistance in Insulin-Dependent Diabetes Mellitus: A Major Role for Reduced Skeletal Muscle Blood Flow* 1991 ·The Journal of Clinical Endocrinology & Metabolism ·Alain Baron, Markku Laakso, Ginger Brechtel, Steven V. Edelman	180
19	Reduced Postprandial Skeletal Muscle Blood Flow Contributes to Glucose Intolerance in Human Obesity* 1990 ·The Journal of Clinical Endocrinology & Metabolism ·Alain Baron, Markku Laakso, Ginger Brechtel, Brian D. Hoit, (unknown), Steven V. Edelman	134
20	Fasting Decreases Rates of Noninsulin-Mediated Glucose Uptake in Man* 1988 ·The Journal of Clinical Endocrinology & Metabolism ·Alain Baron, Ginger Brechtel, Penny Wallace, Steven V. Edelman	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact